Candel Therapeutics, Inc. (CADL) vs Cytek Biosciences, Inc. (CTKB)
A side-by-side comparison of Candel Therapeutics, Inc. and Cytek Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CADL
Candel Therapeutics, Inc.
$10.15HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
CTKB
Cytek Biosciences, Inc.
$5.77HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — CADL vs CTKB
growth of $100 · dividends reinvested · last 5yCADL +46.1% (+7.9%/yr)CTKB -65.2% (-19.1%/yr)CADL compounded faster over this window
CADL CTKB
CADL vs CTKB: by the numbers
- •CTKB is the larger company ($745M vs $744M market cap).
- •Both run net losses; CADL's is the smaller (0.00% vs -38.98% net margin).
Metrics side by side
Valuation
| Metric | CADL | CTKB |
|---|---|---|
| P/S ratio | N/A | 3.60 |
| P/B ratio | 5.90 | 2.31 |
Profitability
| Metric | CADL | CTKB |
|---|---|---|
| Gross margin | 0.00% | 53.23% |
| Operating margin | 0.00% | -21.60% |
| Net margin | 0.00% | -38.98% |
| ROE | -70.19% | -25.03% |
| ROIC | -36.83% | -12.00% |
Growth (annualized)
| Metric | CADL | CTKB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.37% |
| Total return CAGR (5Y) | -1.42% | -23.16% |
Frequently asked
- How have CADL and CTKB total returns compared?
- Over the past 5 years, CADL delivered -1.42% and CTKB delivered -23.16% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.